German Spondyloarthritis Inception Cohort
This trial is active, not recruiting.
|Conditions||ankylosing spondylitis, non-radiographic axial spondyloarthritis|
|Sponsor||Charite University, Berlin, Germany|
|Collaborator||German Federal Ministry of Education and Research (BMBF): 2000-2007 and since 2010|
|Start date||July 2000|
|End date||July 2018|
|Trial size||803 participants|
|Trial identifier||NCT01277419, GESPIC|
The German Spondyloarthritis Inception cohort (GESPIC) was started as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis and non-radiographic axial. The objectives of GESPIC are to learn about the course of AS and other SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs).
Male or female participants of any age.
Inclusion Criteria: - AS fulfilling the modified New York criteria, and the duration of AS symptoms (usually back pain) ≤10 years at the time of inclusion. - Non-radiographic axial SpA fulfilling the European Spondylarthropathy Study Group (ESSG) criteria with the maximum duration of symptoms ≤5 years and no radiographic changes in the SI joints of at least grade II bilaterally or grade III or IV unilaterally - Juvenile SpA - fulfilment of the modified NY/ESSG criteria and age of symptoms onset ≤16 years
|Official title||German Spondyloarthritis Inception Cohort|
|Principal investigator||Joachim Sieper, Prof. Dr.|
Call for more information